Literature DB >> 19844133

Gender-based differences in drug prescription: relation to adverse drug reactions.

Y Zopf1, C Rabe, A Neubert, C Janson, K Brune, E G Hahn, H Dormann.   

Abstract

BACKGROUND/AIM: The female gender appears to suffer from more adverse drug reactions (ADRs) than the male gender. So far, there has been no epidemiologic study analyzing gender-based differences in drug prescribing and its ADR risks. The aim of the present study was to establish a drug risk stratification adjusted to age, number of prescriptions and drug classes with respect to gender differences based on intensive data acquisition methods.
METHOD: A prospective multicenter study was conducted in several departments in Germany and Israel (pediatrics, medicine and geriatrics) enclosing 2,371 inpatients.
RESULTS: A total of 25,532 drug prescriptions during hospitalization were evaluated. At least 1 ADR was found in 774 patients (32.6%). Drugs for the cardiovascular system, nervous system, alimentary tract and musculoskeletal system were prescribed most often in females. The following drug classes led significantly more often to ADRs in women as compared to men: alimentary tract (OR 0.5; p = 0.0002), cardiovascular system (OR 0.72; p = 0.0140), musculoskeletal system (OR 0.31; p = 0.0004) and nervous system (OR 0.62; p = 0.0023). After adjustment to age, total number of prescriptions and drug class, only anti-infectives (antibacterials) and musculoskeletal system (anti-inflammatory) drugs stand out as causing more ADRs in women.
CONCLUSION: Antibacterials and anti-inflammatory agents cause more ADRs in females as compared to males. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844133     DOI: 10.1159/000248311

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  12 in total

1.  Adverse drug reactions in internal medicine units and associated risk factors.

Authors:  Juan Francisco Sánchez Muñoz-Torrero; Paloma Barquilla; Raul Velasco; Maria del Carmen Fernández Capitan; Nazaret Pacheco; Lucia Vicente; Jose Luis Chicón; Sara Trejo; Jose Zamorano; Alicia Lorenzo Hernandez
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

2.  Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug-drug interactions.

Authors:  Emmanuel Eschmann; Patrick E Beeler; Vladimir Kaplan; Markus Schneemann; Gregor Zünd; Jürg Blaser
Journal:  Eur J Clin Pharmacol       Date:  2013-10-23       Impact factor: 2.953

Review 3.  A cytoprotective perspective on longevity regulation.

Authors:  David E Shore; Gary Ruvkun
Journal:  Trends Cell Biol       Date:  2013-05-30       Impact factor: 20.808

4.  Frequent Adverse Drug Reactions, and Medication Groups under Suspicion.

Authors:  Diana Dubrall; Matthias Schmid; Eva Alešik; Norbert Paeschke; Julia Stingl; Bernhardt Sachs
Journal:  Dtsch Arztebl Int       Date:  2018-06-08       Impact factor: 5.594

5.  Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6.

Authors:  Waja Wegner; Birgitta Christina Burckhardt; Gerhard Burckhardt; Maja Henjakovic
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

6.  Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events.

Authors:  Yue Yu; Jun Chen; Dingcheng Li; Liwei Wang; Wei Wang; Hongfang Liu
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

7.  Sex differences in drugs: the development of a comprehensive knowledge base to improve gender awareness prescribing.

Authors:  Linnéa Karlsson Lind; Mia von Euler; Seher Korkmaz; Karin Schenck-Gustafsson
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

8.  Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016.

Authors:  Yimin Xu; Dhavalkumar N Patel; Suet-Leng P Ng; Siew-Har Tan; Dorothy Toh; Jalene Poh; Adena Theen Lim; Cheng-Leng Chan; Min-Yong Low; Hwee-Ling Koh
Journal:  Front Med (Lausanne)       Date:  2018-06-12

9.  Estrogen receptor α (ERα) indirectly induces transcription of human renal organic anion transporter 1 (OAT1).

Authors:  Anna M Euteneuer; Tamina Seeger-Nukpezah; Hendrik Nolte; Maja Henjakovic
Journal:  Physiol Rep       Date:  2019-11

10.  Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study.

Authors:  Claudia Giardina; Paola M Cutroneo; Eleonora Mocciaro; Giuseppina T Russo; Giuseppe Mandraffino; Giorgio Basile; Franco Rapisarda; Rosarita Ferrara; Edoardo Spina; Vincenzo Arcoraci
Journal:  Front Pharmacol       Date:  2018-04-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.